NO20062071L - Muskariniske acetylkolin-reseptorantangonister - Google Patents
Muskariniske acetylkolin-reseptorantangonisterInfo
- Publication number
- NO20062071L NO20062071L NO20062071A NO20062071A NO20062071L NO 20062071 L NO20062071 L NO 20062071L NO 20062071 A NO20062071 A NO 20062071A NO 20062071 A NO20062071 A NO 20062071A NO 20062071 L NO20062071 L NO 20062071L
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonists
- acetylcholine receptor
- muscarinic acetylcholine
- muscarinic
- antagonists
- Prior art date
Links
- 229940121683 Acetylcholine receptor antagonist Drugs 0.000 title abstract 2
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 title abstract 2
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51216103P | 2003-10-17 | 2003-10-17 | |
| PCT/US2004/034234 WO2005037224A2 (en) | 2003-10-17 | 2004-10-15 | Muscarinic acetylcholine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062071L true NO20062071L (no) | 2006-05-08 |
Family
ID=34465319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062071A NO20062071L (no) | 2003-10-17 | 2006-05-08 | Muskariniske acetylkolin-reseptorantangonister |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7507747B2 (is) |
| EP (1) | EP1677796A4 (is) |
| JP (1) | JP2007509061A (is) |
| CN (1) | CN1897947A (is) |
| AP (1) | AP2006003575A0 (is) |
| AR (1) | AR046114A1 (is) |
| AU (1) | AU2004281167A1 (is) |
| BR (1) | BRPI0415281A (is) |
| CA (1) | CA2542636A1 (is) |
| EA (1) | EA200600787A1 (is) |
| EC (1) | ECSP066486A (is) |
| IL (1) | IL174846A0 (is) |
| IS (1) | IS8440A (is) |
| MA (1) | MA28109A1 (is) |
| MX (1) | MXPA06004242A (is) |
| NO (1) | NO20062071L (is) |
| OA (1) | OA13270A (is) |
| PE (1) | PE20050442A1 (is) |
| TW (1) | TW200528448A (is) |
| UY (1) | UY28567A1 (is) |
| WO (1) | WO2005037224A2 (is) |
| ZA (1) | ZA200602783B (is) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200519108A (en) * | 2003-07-17 | 2005-06-16 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| TW200524577A (en) * | 2003-11-04 | 2005-08-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| WO2005087236A1 (en) * | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| WO2005095407A1 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| WO2005094251A2 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3muscarinic acetylcholine receptor antagonists |
| AR050902A1 (es) | 2004-04-27 | 2006-12-06 | Glaxo Group Ltd | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion |
| EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
| JP2008520579A (ja) * | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト |
| EP1937267A4 (en) * | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
| US7767691B2 (en) * | 2005-08-18 | 2010-08-03 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system |
| AR070564A1 (es) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | Derivados de 1h-pirazolo[3,4-b]piridin-5-ilo,inhibidores de fosfodiesterasas pde4 y antagonistas de receptores muscarinicos de acetilcolina(machr), utiles en el tratamiento y/o profilaxis de enfermedades respiratorias y alergicas,y composiciones farmaceuticas que los comprenden |
| UY31637A1 (es) | 2008-02-06 | 2009-08-03 | Farmacoforos duales-antagonistas muscarinicos de pde4 | |
| CL2009000249A1 (es) | 2008-02-06 | 2009-09-11 | Glaxo Group Ltd | Compuestos derivados de pirazolo[3,4-b] piridin-butanodiamida; composicion farmaceutica; y su uso en el tratamiento del asma, enfermedad pulmonar obstructiva cronica, rinitis, dermatitis atopica, psoriasis. |
| WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2800481A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
| US2800478A (en) * | 1955-07-01 | 1957-07-23 | Smith Kline French Lab | 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof |
| AT298118B (de) * | 1967-06-08 | 1972-04-25 | Siemens Ag | Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens |
| CY1308A (en) | 1979-12-06 | 1985-12-06 | Glaxo Group Ltd | Device for dispensing medicaments |
| EP0069715B1 (en) | 1981-07-08 | 1986-11-05 | Aktiebolaget Draco | Powder inhalator |
| GB2169265B (en) | 1982-10-08 | 1987-08-12 | Glaxo Group Ltd | Pack for medicament |
| DK172541B1 (da) | 1982-10-08 | 1998-12-07 | Glaxo Group Ltd | Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet |
| CH667657A5 (de) * | 1985-01-07 | 1988-10-31 | Sandoz Ag | Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine. |
| AU591152B2 (en) | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
| IT1204826B (it) | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
| GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
| US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
| WO1998024788A1 (en) * | 1996-12-02 | 1998-06-11 | Georgetown University | Tropane derivatives and method for their synthesis |
| US6248752B1 (en) * | 1998-02-27 | 2001-06-19 | Charles Duane Smith | Azabicyclooctane compositions and methods for enhancing chemotherapy |
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| US6552036B2 (en) * | 2000-03-03 | 2003-04-22 | Ortho-Mcneil Pharmaceutical, Inc. | 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| RU2004110717A (ru) * | 2001-10-17 | 2005-10-20 | Юсиби, С.А. (Be) | Производные хинуклидина, способы их получения и их применение в качестве и нгибиторов м2- и/или м3- мускариновых рецепторов |
| US6696462B2 (en) * | 2002-01-31 | 2004-02-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions |
| UY27927A1 (es) * | 2002-08-06 | 2003-12-31 | Glaxo Group Ltd | Antagonistas del receptor muscarínico m3 de acetilcolina |
| WO2004091482A2 (en) * | 2003-04-07 | 2004-10-28 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| PE20050711A1 (es) * | 2003-07-17 | 2005-09-10 | Glaxo Group Ltd | Compuestos 8-azoniabiciclo[3.2.1] octanos como antagonistas de los receptores muscarinicos de la acetilcolina |
| PE20050327A1 (es) * | 2003-07-17 | 2005-06-08 | Glaxo Group Ltd | Derivados de 8-azoniabiciclo[3.2.1]octano como antagonistas de los receptores muscarinicos de la acetilcolina |
| TW200519108A (en) * | 2003-07-17 | 2005-06-16 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| CN101230061A (zh) * | 2003-10-14 | 2008-07-30 | 葛兰素集团有限公司 | 蕈毒碱性乙酰胆碱受体拮抗剂 |
| TW200524577A (en) * | 2003-11-04 | 2005-08-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| ES2329586T3 (es) * | 2003-11-21 | 2009-11-27 | Theravance, Inc. | Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino. |
| UY28645A1 (es) * | 2003-12-03 | 2005-06-30 | Glaxo Group Ltd | Nuevos antagonistas del receptor muscarinico m3 de acetilcolina |
| PE20050861A1 (es) * | 2003-12-03 | 2005-12-10 | Glaxo Group Ltd | Derivados de sales ciclicas de amonio cuaternario como antagonistas del receptor muscarinico de acetilcolina |
| US20070185088A1 (en) * | 2004-03-17 | 2007-08-09 | Jakob Busch-Petersen | M3 muscarinic acetylchoine receptor antagonists |
| WO2005094251A2 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3muscarinic acetylcholine receptor antagonists |
| WO2005095407A1 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| US20070185090A1 (en) * | 2004-03-17 | 2007-08-09 | Jakob Busch-Petersen | Muscarinic acetylchoine receptor antagonists |
| AR050902A1 (es) * | 2004-04-27 | 2006-12-06 | Glaxo Group Ltd | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion |
| EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
| TW200606161A (en) * | 2004-05-28 | 2006-02-16 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| JP2008520579A (ja) | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト |
| WO2006055503A2 (en) | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| PE20061162A1 (es) | 2004-12-06 | 2006-10-14 | Smithkline Beecham Corp | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos |
| PE20060826A1 (es) | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
| WO2006065788A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Novel muscarinic acetylcholine receptor antagonists |
| WO2006065755A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
| WO2007018514A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| WO2007018508A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetycholine receptor antagonists |
-
2004
- 2004-10-15 MX MXPA06004242A patent/MXPA06004242A/es not_active Application Discontinuation
- 2004-10-15 BR BRPI0415281-6A patent/BRPI0415281A/pt not_active Application Discontinuation
- 2004-10-15 AP AP2006003575A patent/AP2006003575A0/xx unknown
- 2004-10-15 TW TW093131251A patent/TW200528448A/zh unknown
- 2004-10-15 AU AU2004281167A patent/AU2004281167A1/en not_active Abandoned
- 2004-10-15 OA OA1200600124A patent/OA13270A/en unknown
- 2004-10-15 PE PE2004001004A patent/PE20050442A1/es not_active Application Discontinuation
- 2004-10-15 CA CA002542636A patent/CA2542636A1/en not_active Abandoned
- 2004-10-15 CN CNA2004800380467A patent/CN1897947A/zh active Pending
- 2004-10-15 EP EP04795406A patent/EP1677796A4/en not_active Withdrawn
- 2004-10-15 AR ARP040103734A patent/AR046114A1/es not_active Application Discontinuation
- 2004-10-15 US US10/575,837 patent/US7507747B2/en not_active Expired - Fee Related
- 2004-10-15 JP JP2006535384A patent/JP2007509061A/ja active Pending
- 2004-10-15 EA EA200600787A patent/EA200600787A1/ru unknown
- 2004-10-15 UY UY28567A patent/UY28567A1/es not_active Application Discontinuation
- 2004-10-15 WO PCT/US2004/034234 patent/WO2005037224A2/en not_active Ceased
-
2006
- 2006-04-05 ZA ZA200602783A patent/ZA200602783B/xx unknown
- 2006-04-06 EC EC2006006486A patent/ECSP066486A/es unknown
- 2006-04-06 IL IL174846A patent/IL174846A0/en unknown
- 2006-04-25 MA MA28963A patent/MA28109A1/fr unknown
- 2006-05-05 IS IS8440A patent/IS8440A/is unknown
- 2006-05-08 NO NO20062071A patent/NO20062071L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0415281A (pt) | 2006-12-19 |
| OA13270A (en) | 2007-01-31 |
| CN1897947A (zh) | 2007-01-17 |
| TW200528448A (en) | 2005-09-01 |
| ZA200602783B (en) | 2007-11-28 |
| EP1677796A2 (en) | 2006-07-12 |
| AP2006003575A0 (en) | 2006-04-30 |
| WO2005037224A2 (en) | 2005-04-28 |
| IL174846A0 (en) | 2006-08-20 |
| PE20050442A1 (es) | 2005-07-09 |
| US20070135478A1 (en) | 2007-06-14 |
| AR046114A1 (es) | 2005-11-23 |
| EA200600787A1 (ru) | 2006-08-25 |
| MXPA06004242A (es) | 2006-06-28 |
| US7507747B2 (en) | 2009-03-24 |
| AU2004281167A1 (en) | 2005-04-28 |
| WO2005037224A3 (en) | 2005-06-23 |
| EP1677796A4 (en) | 2006-12-27 |
| CA2542636A1 (en) | 2005-04-28 |
| UY28567A1 (es) | 2005-05-31 |
| JP2007509061A (ja) | 2007-04-12 |
| IS8440A (is) | 2006-05-05 |
| MA28109A1 (fr) | 2006-08-01 |
| ECSP066486A (es) | 2006-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062042L (no) | Muskariniske acetylkolin reseptorantangonister | |
| UA95768C2 (ru) | Антагонисты мускариновых рецепторов ацетилхолина | |
| NO20063032L (no) | Nye M3 muskarinacetylkolinreceptorantagoniser | |
| CY1113295T1 (el) | Ανταγωνιστες m3 μουσκαρινικου υποδοχεα ακετυλοχολινης | |
| UY27927A1 (es) | Antagonistas del receptor muscarínico m3 de acetilcolina | |
| NO20062992L (no) | Nye M3 muskarine acetykolinreseptorantagonister | |
| NO20060777L (no) | Muskarine acetylkolinreseptorantagonister | |
| TW200600093A (en) | M3 muscarinic acetylcholine receptor antagonists | |
| MXPA06000662A (es) | Antagonistas del receptor muscarinico de acetilcolina. | |
| NO20060776L (no) | Muskarine acetylkolinreseptorantagonister | |
| NO20063636L (no) | Muskariniske acetylkolinrecptoorantagonister | |
| TW200633715A (en) | Medical combinations | |
| IS8526A (is) | CRF viðtakamótlyf og aðferðir tengdar þeim | |
| BRPI0415281A (pt) | antagonistas de receptor de acetilcolina muscarìnico | |
| TW200606161A (en) | Muscarinic acetylcholine receptor antagonists | |
| TW200600500A (en) | M3 muscarinic acetylcholine receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |